$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Moderna To $74? Here Are 5 Other Price Target Changes For Thursday
12:16pm, Thursday, 04'th Aug 2022 Benzinga
Jefferies cut the price target on Medifast, Inc. (NYSE: MED) from $345 to $150. However, Jefferies analyst Stephanie Wissink downgraded the stock from Buy to Hold. Medifast shares fell 12.7% to $149
Biden's isolation under White House protocol requires a negative test before in-person work. That's stricter than CDC guidelines.
11:48am, Thursday, 04'th Aug 2022 MarketWatch
President Joe Biden will not resume in-person work until he tests negative for COVID, under White House protocols that are stricter than the CDC guidelines.
This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday
09:54am, Thursday, 04'th Aug 2022 Benzinga
Gainers
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume.
ECMOHO Limited (NASDAQ: MOHO) jumped 146.1% to settle at $0.4085 on a
Market Volatility Declines Sharply After Nasdaq Jumps More Than 300 Points
08:01am, Thursday, 04'th Aug 2022 Benzinga
U.S. stocks rose sharply on Wednesday, with Treasury yields climbing to two-week highs on Wednesday following better-than-expected economic data and strong projections from some major companies.
All t
How Siga Is Turning Its Biowarfare Soldier Onto This Outbreak
08:00am, Thursday, 04'th Aug 2022
The medicine Siga Technologies developed to combat biowarfare is now being used in the ongoing viral outbreak, and Siga stock has exploded.
Moderna, PayPal And Some Other Big Gainers From Wednesday
08:00am, Thursday, 04'th Aug 2022 Benzinga
U.S. stocks closed higher on Wednesday, with the Dow Jones gaining more than 400 points. Here is the list of some big stocks moving higher in the previous session.
Ping Identity Holding Corp. (NYSE:
U.S. stocks book powerful gains after rosy corporate earnings, economic data calm recession fears
08:47pm, Wednesday, 03'rd Aug 2022 MarketWatch
U.S. stock indexes closed higher on Wednesday as investors weighed earnings reports and economic data after kicking off August with back-to-back losses.
Tech Stocks Surging: 5 Stocks Sending the Nasdaq Higher on Wednesday
08:28pm, Wednesday, 03'rd Aug 2022 The Motley Fool
A combination of solid earnings and investor optimism has many of the year's losers seeing some gains.
Nasdaq Surges Over 300 Points; Moderna Earnings Beat Expectations
06:33pm, Wednesday, 03'rd Aug 2022 Benzinga
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 300 points on Wednesday.
The Dow traded up 1.35% to 32,832.23 while the NASDAQ rose 2.55% to 12,664.26.
Moderna Q2 Earnings, Buyback Plans Lift Biotech ETFs
06:23pm, Wednesday, 03'rd Aug 2022
Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue in i
Moderna Inc. (MRNA) Q2 2022 Earnings Call Transcript
05:00pm, Wednesday, 03'rd Aug 2022 The Motley Fool
MRNA earnings call for the period ending June 30, 2022.
Why Poseida Therapeutics Almost Doubled Today, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session
04:59pm, Wednesday, 03'rd Aug 2022 Benzinga
Gainers
Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday.
Kaspien Holdings Inc. (NASDAQ: KSPN) gained 112.4% to $5.48.
Eargo, Inc. (NASDAQ: E
Moderna (MRNA) Beats on Q2 Earnings, Starts $3B Buyback Program
04:47pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Moderna's (MRNA) earnings and sales beat expectations. The company also announces another $3-billion buyback program. Stock gains in pre-market.
Moderna Just Gave Investors 499 Million Reasons to Worry
03:34pm, Wednesday, 03'rd Aug 2022 The Motley Fool
Investors are cheering the company's Q2 results. But there was a troubling detail in Moderna's update.
U.S. Stock Futures Rise on Strong Q2 Earnings
02:24pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Stock futures have risen in today???s pre-market after two consecutive days of loss making.
Sign In
Buy MRNA